BioLineRx (BLRX) Earnings Analysis
BioLineRx (BLRX) next reports earnings on 2026-08-13, consensus EPS -0.15 USD. Last quarter (2026-05-27) it beat with EPS -0.36 USD vs -1.04 USD est (+65.4%). It has beaten estimates in 5/7 recent quarters (71%). Trailing P/E -1.36.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does BLRX next report earnings?
| Next earnings date | 2026-08-13 |
|---|---|
| Consensus EPS estimate | -0.15 USD |
| Revenue estimate | 0.00B |
BLRX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-27 | -0.36 USD | -1.04 USD | +65.4% | Beat |
| 2026-03-23 | -0.27 USD | -0.385 USD | +29.9% | Beat |
| 2025-11-24 | -0.22 USD | -0.41 USD | +46.3% | Beat |
| 2025-08-14 | -1 USD | -0.35 USD | -185.7% | Miss |
| 2025-05-27 | 1.39 USD | -0.84 USD | +265.5% | Beat |
| 2024-11-25 | -2.8 USD | -0.05 USD | -5500% | Miss |
| 2024-08-15 | 0.4 USD | -0.14 USD | +385.7% | Beat |
Beat rate: 5/7 (71%) over reported quarters with consensus data.
BLRX valuation and analyst view
| Trailing P/E | -1.36 |
|---|---|
| Trailing EPS | -0.0502 USD |
| Price / book | 0.78 |
| Dividend yield | 0.00% |
| Market cap | 0.01B |
| Analyst consensus | Buy (7 buy / 0 hold / 0 sell) |
Related research pages
Frequently asked questions
When is BioLineRx (BLRX)'s next earnings date?
BioLineRx is next scheduled to report on 2026-08-13, with a consensus EPS estimate of -0.15 USD and revenue estimate of 0.00B.
Did BLRX beat earnings last quarter?
In its 2026-05-27 report, BLRX posted EPS of -0.36 USD versus a -1.04 USD estimate — a beat of 65.4%.
What is BLRX's earnings track record?
Over the last 7 reported quarters with consensus data, BLRX beat estimates 5 times (71%).
What is BLRX's current P/E ratio and EPS?
BLRX trades at a trailing P/E of -1.36 on trailing EPS of -0.0502 USD.
What do analysts rate BLRX?
Analyst consensus is "Buy" across 7 ratings (0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell).